𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PRIMA-1 synergizes with adriamycin to induce cell death in non-small cell lung cancer cells

✍ Scribed by R. Magrini; D. Russo; L. Ottaggio; G. Fronza; A. Inga; P. Menichini

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
339 KB
Volume
104
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

p53‐dependent apoptosis is important for the efficacy of cancer treatment, and tumors carrying mutant p53 are often resistant to chemotherapy. Non‐small cell lung cancer (NSCLC) cells generally exhibit resistance to apoptosis following treatment with many cytotoxic drugs. The new molecule PRIMA‐1 appears to kill human tumor cells by restoring the transcriptional activity to mutated p53. We investigated the induction of apoptosis in response to this drug in three NSCLC cell lines carrying different p53 proteins: A549 (p53wt), LX1 (p53R273H), and SKMes1 (p53R280K). PRIMA‐1 alone did not trigger apoptosis but significantly reduced cell viability. However, in combination with adriamycin, PRIMA‐1 strengthen the adriamycin‐induced apoptosis in A549 and LX1. Interestingly, even in SKMes1 cells, the combined treatment triggered a strong PARP cleavage without DNA fragmentation. Our data suggest that in NSCLC cells, PRIMA‐1 may induce cell death through pathways other than apoptosis but may synergize with adriamycin to trigger an apoptotic response. J. Cell. Biochem. 104: 2363–2373, 2008. © 2008 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Aberrant methylation of TMS1 in small ce
Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer
✍ Arvind Virmani; Asha Rathi; Kenji Sugio; Ubaradka G. Sathyanarayana; Shinichi To 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 320 KB 👁 2 views

## Abstract __TMS1__ (target of methylation‐induced silencing) is a CpG island‐associated gene that functions in the regulation of apoptosis and encodes a caspase recruitment domain, a recently described motif found in apoptotic signaling molecules. Recent evidence suggests that silencing of genes

PED interacts with Rac1 and regulates ce
PED interacts with Rac1 and regulates cell migration/invasion processes in human non-small cell lung cancer cells
✍ Ciro Zanca; Flora Cozzolino; Cristina Quintavalle; Stefania Di Costanzo; Lucia R 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 363 KB

## Abstract PED (phosphoprotein enriched in diabetes) is a 15 kDa protein involved in many cellular pathways and human diseases including type II diabetes and cancer. We recently reported that PED is overexpressed in human cancers and mediates resistance to induced apoptosis. To better understand i

ATM sequence variants associate with sus
ATM sequence variants associate with susceptibility to non-small cell lung cancer
✍ Hushan Yang; Margaret R. Spitz; David J. Stewart; Charles Lu; Ivan P. Gorlov; Xi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 97 KB 👁 1 views

## Abstract __ATM__ gene mutations have been implicated in many human cancers. However, the role of __ATM__ polymorphisms in lung carcinogenesis is largely unexplored. We conducted a case‐control analysis of 556 Caucasian non‐small‐cell lung cancer (NSCLC) patients and 556 controls frequency‐matche

Silibinin synergizes with mitoxantrone t
Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in human prostate cancer cells
✍ Thomas W. Flaig; Lih-Jen Su; Gail Harrison; Rajesh Agarwal; Leonard Michael Glod 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 265 KB 👁 2 views

## Abstract The purpose of these experiments was to assess the synergistic activity of silibinin with chemotherapy agents in clinical use against prostate cancer. Silybin‐phytosome, a commercially available formulation containing silibinin, has recently been studied in a phase I clinical trial. The